AbbVie ABBV has built a substantial oncology franchise in recent years. Initially anchored by blood cancer drugs Imbruvica ...

Pfizer ( PFE) is number one and the leader in my list of "top 3 Big Pharma stocks." Over the last three quarters I have seen ...

These Goldman Sachs stock picks are poised for growth in 2026 and will continue to pay and raise their significant and ...

Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with ...

Summit Therapeutics shares Phase 3 data showing ivonescimab cut cancer progression risk by 40% and plans BLA submission in ...

The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...

Yahoo Finance is chronicling the latest news and updates on President Trump's plans to impose tariffs on goods from other ...

Merck MRK is facing persistent challenges for its second-largest product, Gardasil, which is a vaccine for the prevention of ...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

Forget the wealthy. Why this value manager is betting on average Americans, and the stocks he's buying now. When stocks start to crumble, Smead Capital Management's Bill Smead says investors need to ...

Merck & Co., Inc. finds itself at a pivotal point as recent events stir the pot in the pharmaceutical landscape. With the ...